Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.
Akiska YM, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender VD, Castelo-Soccio L, Cotsarelis G, Craiglow BG, Desai NS, Doche I, Duque-Estrada B, Elston DM, Goh C, Goldberg LJ, Grimalt R, Jabbari A, Jolliffe V, King BA, LaSenna C, Lenzy Y, Lester JC, Lortkipanidze N, Lo Sicco KI, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini BM, Rakowska A, Salkey KS, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall DR, Fu JM. Akiska YM, et al. Among authors: piliang m. JAMA Dermatol. 2025 Jan 1;161(1):87-95. doi: 10.1001/jamadermatol.2024.4593. JAMA Dermatol. 2025. PMID: 39565602
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.
Piliang M, Soung J, King B, Shapiro J, Rudnicka L, Farrant P, Magnolo N, Piraccini BM, Luo X, Wolk R, Woodworth D, Schaefer G, Lejeune A. Piliang M, et al. Br J Dermatol. 2025 Jan 24;192(2):215-227. doi: 10.1093/bjd/ljae365. Br J Dermatol. 2025. PMID: 39432738 Clinical Trial.
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial.
Piliang M, Lynde C, King B, Mirmirani P, Sinclair R, Senna M, Forman S, Bordone L, De La Cueva Dobao P, Wolk R, Zwillich SH, Tran H, Wajsbrot D, Ahmed HM, Takiya L. Piliang M, et al. J Am Acad Dermatol. 2025 Feb;92(2):276-284. doi: 10.1016/j.jaad.2024.09.064. Epub 2024 Oct 17. J Am Acad Dermatol. 2025. PMID: 39423930 Free article. Clinical Trial.
Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendations.
Jackson T, Sow Y, Dinkins J, Aguh C, Omueti Ayoade K, Barbosa V, Burgess C, Callender V, Cotsarelis G, Grimes P, Harvey V, Kindred C, Lester J, Lo Sicco K, Mayo T, McMichael A, Oboite M, Ogunleye T, Olsen E, Osei-Tutu A, Piliang M, Senna M, Shapiro J, Tosti A, Frey C, Adotama P, Taylor SC. Jackson T, et al. Among authors: piliang m. J Am Acad Dermatol. 2024 Jun;90(6):1182-1189. doi: 10.1016/j.jaad.2023.12.073. Epub 2024 Feb 9. J Am Acad Dermatol. 2024. PMID: 38341148
Approach to the patient with hair loss.
Workman K, Piliang M. Workman K, et al. Among authors: piliang m. J Am Acad Dermatol. 2023 Aug;89(2S):S3-S8. doi: 10.1016/j.jaad.2023.05.040. J Am Acad Dermatol. 2023. PMID: 37591563 Review.
A clinicopathologic analysis of 54 cases of cutaneous myxoma.
Sharma A, Khaitan N, Ko JS, Bergfeld WF, Piliang M, Rubin BP, Goldblum JR, Billings SD. Sharma A, et al. Among authors: piliang m. Hum Pathol. 2022 Feb;120:71-76. doi: 10.1016/j.humpath.2021.12.003. Epub 2021 Dec 27. Hum Pathol. 2022. PMID: 34968506
97 results